Back to Trades
Parschauer Karah Herdman
InsiderCIK 0001677455
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 3
- Active
- 2025–2026
Parschauer Karah Herdman has filed 7 SEC reports (2025–2026), spread across 3 companies, totaling $1.7M in disclosed volume. Weighing $0 bought versus $355.9K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Aug 4 | RARE Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | Insider | Sell | $47.3K |
| Jun 15 | RARE Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | Insider | Sell | $46.8K |
| May 29 | TNYA Tenaya Therapeutics, Inc. | Parschauer Karah Herdman | Insider | Award | $95.9K |
| Apr 20 | RARE Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | Insider | Grant | $1.2M |
| Mar 3 | RARE Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | Insider | Sell | $185.5K |
| Feb 19 | EOLS Evolus, Inc. | Parschauer Karah Herdman | Director | Grant | $0 |
| Sep 12 | RARE Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | Insider | Sell | $76.4K |
7 filings